BCO.HM
Price
Day trading desk
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
5 more panels on BCO.HM open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Valuation & profitability ratios
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $89.46B | $66.52B | $77.79B | $66.61B | +34.5% |
| Operating revenue | $89.46B | $66.52B | $77.79B | $66.61B | +34.5% |
| Cost of revenue | $85.17B | $68.51B | $70.07B | $63.08B | +24.3% |
| Gross profit | $4.29B | -$1.99B | $7.72B | $3.53B | +315.4% |
| Research & development | $3.62B | $3.81B | $3.38B | $2.85B | -5.2% |
| Selling, general & admin | $6.09B | $5.02B | $5.17B | $4.19B | +21.3% |
| Total operating expense | $9.71B | $8.83B | $8.54B | $7.04B | +9.9% |
| Operating income | -$5.42B | -$10.82B | -$821.00M | -$3.51B | +50.0% |
| Net interest income | -$2.77B | -$2.73B | -$2.46B | -$2.56B | -1.7% |
| Pre-tax income | $2.63B | -$12.21B | -$2.00B | -$5.02B | +121.6% |
| Tax provision | $397.00M | -$381.00M | $237.00M | $31.00M | +204.2% |
| Net income | $2.23B | -$11.82B | -$2.22B | -$4.93B | +118.9% |
| Net income to common | $1.89B | -$11.88B | -$2.22B | -$4.93B | +115.9% |
| Basic EPS | 2.49 | -18.36 | -3.67 | -8.30 | +113.6% |
| Diluted EPS | 2.48 | -18.36 | -3.67 | -8.30 | +113.5% |
| EBIT | $5.41B | -$9.48B | $454.00M | -$2.46B | +157.0% |
| EBITDA | $7.36B | -$7.65B | $2.31B | -$482.00M | +196.2% |
| Basic shares | 759.04M | 643.63M | 605.45M | 594.58M | +17.9% |
| Diluted shares | 762.30M | 647.20M | 606.10M | 595.20M | +17.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $10.92B | $13.80B | $12.69B | $14.61B | -20.9% |
| Cash & short-term investments | $29.40B | $26.28B | $15.96B | $17.22B | +11.9% |
| Accounts receivable | $2.77B | $2.72B | $2.71B | $2.63B | +2.1% |
| Inventory | $84.68B | $87.55B | $79.74B | $78.15B | -3.3% |
| Total current assets | $128.46B | $128.00B | $109.28B | $109.52B | +0.4% |
| Property, plant & equipment | $15.60B | $11.73B | $11.52B | $12.00B | +33.1% |
| Goodwill & intangibles | $18.84B | $10.04B | $10.19B | $10.37B | +87.7% |
| Total assets | $168.24B | $156.36B | $137.01B | $137.10B | +7.6% |
| Total current liabilities | $108.11B | $97.08B | $95.83B | $90.05B | +11.4% |
| Current debt | $8.35B | $1.19B | $5.13B | $5.13B | +600.5% |
| Long-term debt | $45.50B | $52.43B | $46.93B | $51.67B | -13.2% |
| Total debt | $54.43B | $54.19B | $52.60B | $57.28B | +0.5% |
| Total liabilities | $162.78B | $160.28B | $154.24B | $152.95B | +1.6% |
| Retained earnings | $17.25B | $15.36B | $27.25B | $29.47B | +12.3% |
| Shareholder equity | $5.45B | -$3.91B | -$17.23B | -$15.88B | +239.6% |
| Working capital | $20.34B | $30.92B | $13.45B | $19.47B | -34.2% |
| Net tangible assets | -$13.39B | -$13.95B | -$27.42B | -$26.25B | +4.0% |
| Shares issued | 1.01B | 1.01B | 1.01B | 1.01B | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $2.24B | -$11.83B | -$2.24B | -$5.05B | +118.9% |
| Depreciation & amortisation | $1.95B | $1.84B | $1.86B | $1.98B | +6.4% |
| Stock-based compensation | $426.00M | $407.00M | $690.00M | $725.00M | +4.7% |
| Change in working capital | -$1.00B | -$8.77B | $4.09B | $4.14B | +88.6% |
| Operating cash flow | $1.06B | -$12.08B | $5.96B | $3.51B | +108.8% |
| Capital expenditure | -$2.95B | -$2.32B | -$1.53B | -$1.22B | -27.3% |
| Investing cash flow | $499.00M | -$11.97B | -$2.44B | $4.37B | +104.2% |
| Dividends paid | -$331.00M | — | — | — | — |
| Financing cash flow | -$3.76B | $25.21B | -$5.49B | -$1.27B | -114.9% |
| Free cash flow | -$1.89B | -$14.40B | $4.43B | $2.29B | +86.9% |
| End cash position | $10.92B | $13.80B | $12.69B | $14.61B | -20.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | — | $22.22B | $23.95B | $23.27B | $22.75B | $19.50B | — |
| Operating revenue | — | $22.22B | $23.95B | $23.27B | $22.75B | $19.50B | — |
| Cost of revenue | — | $19.67B | $22.14B | $25.64B | $20.31B | $17.08B | — |
| Gross profit | — | $2.55B | $1.81B | -$2.38B | $2.44B | $2.42B | — |
| Research & development | — | $903.00M | $964.00M | $897.00M | $910.00M | $844.00M | — |
| Selling, general & admin | — | $1.20B | $1.66B | $1.52B | $1.79B | $1.11B | — |
| Total operating expense | — | $2.10B | $2.63B | $2.42B | $2.70B | $1.96B | — |
| Operating income | — | $446.00M | -$815.00M | -$4.79B | -$268.00M | $461.00M | — |
| Net interest income | — | -$616.00M | -$659.00M | -$694.00M | -$710.00M | -$708.00M | — |
| Pre-tax income | — | $26.00M | $8.32B | -$5.20B | -$561.00M | $76.00M | — |
| Tax provision | — | $33.00M | $99.00M | $140.00M | $51.00M | $107.00M | — |
| Net income | — | -$4.00M | $8.22B | -$5.34B | -$611.00M | -$37.00M | — |
| Net income to common | — | -$90.00M | $7.87B | -$5.34B | -$697.00M | -$123.00M | — |
| Basic EPS | -0.67 | -0.11 | 10.59 | — | -0.92 | -0.16 | -509.1% |
| Diluted EPS | -0.67 | -0.11 | 10.23 | — | -0.92 | -0.16 | -509.1% |
| EBIT | — | $642.00M | $8.98B | -$4.50B | $149.00M | $784.00M | — |
| EBITDA | — | $1.22B | $9.51B | -$4.01B | $609.00M | $1.25B | — |
| Basic shares | 790.60M | 788.00M | 768.08M | 747.48M | 664.13M | — | +0.3% |
| Diluted shares | 790.60M | 788.00M | 803.80M | 756.70M | 664.13M | — | +0.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.44B | $10.92B | $6.17B | $7.09B | $10.14B | -13.6% |
| Cash & short-term investments | $20.91B | $29.40B | $22.98B | $22.97B | $23.67B | -28.9% |
| Accounts receivable | $3.48B | $2.77B | $3.31B | $3.19B | $3.20B | +25.7% |
| Inventory | $87.22B | $84.68B | $82.42B | $87.85B | $89.08B | +3.0% |
| Total current assets | $124.14B | $128.46B | $122.13B | $127.30B | $127.66B | -3.4% |
| Property, plant & equipment | $16.15B | $15.60B | $12.32B | $11.98B | $11.77B | +3.5% |
| Goodwill & intangibles | $19.15B | $18.84B | $8.78B | $8.82B | $9.99B | +1.6% |
| Total assets | $164.79B | $168.24B | $150.02B | $155.12B | $156.49B | -2.0% |
| Total current liabilities | $105.55B | $108.11B | $103.32B | $103.38B | $103.65B | -2.4% |
| Current debt | $2.85B | $8.35B | $8.74B | $8.72B | $7.93B | -65.8% |
| Long-term debt | $44.35B | $45.50B | $44.61B | $44.60B | $45.69B | -2.5% |
| Total debt | $47.21B | $54.43B | $53.35B | $53.32B | $53.62B | -13.3% |
| Total liabilities | $158.80B | $162.78B | $158.28B | $158.42B | $159.82B | -2.4% |
| Retained earnings | $17.16B | $17.25B | $9.12B | $14.54B | $15.24B | -0.5% |
| Shareholder equity | $5.99B | $5.45B | -$8.25B | -$3.29B | -$3.33B | +9.8% |
| Working capital | $18.59B | $20.34B | $18.81B | $23.93B | $24.01B | -8.6% |
| Net tangible assets | -$13.16B | -$13.39B | -$17.03B | -$12.12B | -$13.32B | +1.7% |
| Shares issued | 1.01B | 1.01B | 1.01B | 1.01B | 1.01B | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$7.00M | $8.22B | -$5.34B | -$612.00M | -$31.00M | -100.1% |
| Depreciation & amortisation | $573.00M | $536.00M | $491.00M | $460.00M | $466.00M | +6.9% |
| Stock-based compensation | $161.00M | $83.00M | $89.00M | $119.00M | $135.00M | +94.0% |
| Change in working capital | -$1.41B | $1.54B | $304.00M | -$134.00M | -$2.71B | -191.8% |
| Operating cash flow | -$179.00M | $1.33B | $1.12B | $227.00M | -$1.62B | -113.4% |
| Capital expenditure | -$1.27B | -$965.00M | -$885.00M | -$427.00M | -$674.00M | -32.1% |
| Investing cash flow | $5.71B | $6.40B | -$1.96B | -$2.23B | -$1.72B | -10.8% |
| Dividends paid | -$86.00M | -$87.00M | -$86.00M | -$86.00M | -$72.00M | +1.1% |
| Financing cash flow | -$7.03B | -$2.95B | -$87.00M | -$387.00M | -$338.00M | -138.2% |
| Free cash flow | -$1.45B | $366.00M | $238.00M | -$200.00M | -$2.29B | -497.3% |
| End cash position | $9.44B | $10.92B | $6.17B | $7.09B | $10.14B | -13.6% |
Options analytics
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 11, 26 | Argus Research | UPGRADE | Hold | Buy |
| Aug 6, 26 | Tigress Financial | MAINTAINED | Buy | Buy |
| Aug 3, 26 | BNP Paribas | UPGRADE | Underperform | Outperform |
| Jul 29, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 29, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| May 18, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Apr 29, 26 | Tigress Financial | MAINTAINED | Buy | Buy |
| Apr 23, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Apr 2, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Apr 1, 26 | Wells Fargo | INITIATED | — | Overweight |
| Mar 19, 26 | Tigress Financial | MAINTAINED | Buy | Buy |
| Feb 6, 26 | Freedom Broker | MAINTAINED | Buy | Buy |
Headlines
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.